Patent · US Active

TKI permeability enhancers

US11759530B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

City of Hope · US

Inventors

Cy Stein · New City, US
Daniela Castanotto · Altadena, US
David Horne · Duarte, US

Key dates

Filing date	Nov 17, 2015
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Mar 5, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are, inter alia, methods useful for delivering nucleic acids and kinase inhibitors to a cell. The methods provided herein include the delivery of therapeutic nucleic acids to cancer cells by contacting a cancer cell with a kinase inhibitor and a therapeutic nucleic acid. The methods provided herein are therefore, inter alia, useful for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.